Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Micardis Plus Trough/Peak Effect in Hypertension
NCT00257491Phase 3Completed
- Sponsor
- Boehringer Ingelheim
- Start
- Nov 2005
- Primary completion
- Aug 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of hydrochlorothiazide + telmisartan in essential hypertension, sponsored by Boehringer Ingelheim. Started Nov 2005; status: completed.
02
Drugs
hydrochlorothiazide + telmisartan
03
Conditions
essential hypertension
Beyond the preview
Go deeper on NCT00257491.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00257491.